Mersana Therapeutics, Inc. (MRSN)
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.
Address
840 MEMORIAL DRIVE
CAMBRIDGE, MA 02139
Founded
2001
Number of Employees
123
Website
http://www.mersana.com
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at MRSN make a trade.
Creating a free account takes less than one minute